Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isolated limb perfusion for malignant melanoma

H R Alexander1, D L Fraker, D L Bartlett

  • 1Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892-1502, USA.

Seminars in Surgical Oncology
|November 1, 1996
PubMed
Summary

Isolated limb perfusion (ILP) offers targeted cancer treatment for extremity melanoma. New combinations show nearly 90% complete response rates, renewing interest in this effective therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the immediate impact of COVID-19 on surgical oncology practice: Experience from an NCI-designated Comprehensive Cancer Center in the Northeastern United States.

Journal of surgical oncology·2021
Same author

Sentinel lymph node positivity and overall survival in immunosuppressed patients with Merkel cell carcinoma: a national cohort study.

The British journal of dermatology·2020
Same author

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
Same author

<i>SDHB</i> mutation carriers with malignant pheochromocytoma respond better to CVD.

Endocrine-related cancer·2017
Same author

Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.

European journal of cancer (Oxford, England : 1990)·2016
Same author

Preoperative radiotherapy in the management of retroperitoneal liposarcoma.

The British journal of surgery·2016

Area of Science:

  • Oncology
  • Surgical Oncology
  • Pharmacology

Background:

  • Isolated limb perfusion (ILP) is a nearly 40-year-old technique for extremity melanoma.
  • It isolates limb circulation for high-dose chemotherapy delivery, minimizing systemic toxicity.
  • Historically, melphalan with mild hyperthermia was standard, but its role in recurrent melanoma remains debated.

Purpose of the Study:

  • To evaluate the current role and renewed interest in isolated limb perfusion for extremity melanoma.
  • To highlight promising new combination regimens for ILP therapy.

Main Methods:

  • Review of historical and recent clinical experience with isolated limb perfusion.
  • Analysis of treatment outcomes using melphalan, tumor necrosis factor, and interferon-gamma.

Main Results:

  • Previous ILP primarily used melphalan, with debated efficacy for recurrent disease.
  • Recent combination therapy (tumor necrosis factor, melphalan, interferon-gamma) demonstrates high complete response (CR) rates nearing 90%.

Conclusions:

  • Isolated limb perfusion remains a relevant treatment modality for extremity melanoma.
  • Novel combination regimens show significant promise, warranting further clinical evaluation.

Related Experiment Videos